Profound Medical (PROF) Ratios
Profound Medical Ratios
PROF's free cash flow for Q2 2026 was $-11.03M. For the 2026 fiscal year, PROF's free cash flow was decreased by $-4.00 and operating cash flow was $-11.03M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 12.52 | 10.52 | 6.58 | 14.82 | 18.56 |
| Quick Ratio | 11.17 | 9.64 | 5.48 | 12.92 | 16.78 |
| Cash Ratio | 9.83 | 8.36 | 4.12 | 11.12 | 16.16 |
| Solvency Ratio | -0.58 | -2.74 | -2.17 | -2.14 | -4.60 |
| Operating Cash Flow Ratio | -6.41 | -3.57 | -3.50 | -6.16 | -5.38 |
| Short-Term Operating Cash Flow Coverage | -182.85 | -13.50 | -10.60 | -49.33 | 0.00 |
| Net Current Asset Value | $ 1.65M | $ 59.25M | $ 29.16M | $ 49.61M | $ 70.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.07 | 0.18 | 0.13 | 0.02 |
| Debt-to-Equity Ratio | 0.07 | 0.08 | 0.25 | 0.16 | 0.02 |
| Debt-to-Capital Ratio | 0.07 | 0.08 | 0.20 | 0.14 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.05 | 0.14 | 0.16 | 0.00 |
| Financial Leverage Ratio | 2.12 | 1.16 | 1.41 | 1.24 | 1.08 |
| Debt Service Coverage Ratio | -195.96 | -18.49 | -9.35 | -50.10 | -94.89 |
| Interest Coverage Ratio | 0.00 | 0.00 | -37.16 | -170.13 | -99.97 |
| Debt to Market Cap | 0.02 | 0.03 | 0.03 | 0.04 | 0.00 |
| Interest Debt Per Share | 0.16 | 0.21 | 0.41 | 0.40 | 0.08 |
| Net Debt to EBITDA | 1.33 | 1.55 | 0.68 | 1.11 | 2.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.77% | 65.89% | 60.87% | 45.22% | 42.95% |
| EBIT Margin | -256.27% | -309.57% | -387.93% | -422.21% | -444.16% |
| EBITDA Margin | -252.79% | -300.81% | -375.02% | -518.40% | -416.82% |
| Operating Profit Margin | -256.27% | -309.57% | -397.50% | -443.08% | -440.72% |
| Pretax Profit Margin | -262.88% | -260.47% | -398.62% | -424.82% | -445.13% |
| Net Profit Margin | -264.44% | -260.45% | -396.85% | -429.11% | -446.66% |
| Continuous Operations Profit Margin | -264.44% | -260.45% | -396.85% | -429.11% | -446.66% |
| Net Income Per EBT | 100.60% | 99.99% | 99.55% | 101.01% | 100.34% |
| EBT Per EBIT | 102.58% | 84.14% | 100.28% | 95.88% | 101.00% |
| Return on Assets (ROA) | -30.80% | -39.60% | -65.06% | -44.50% | -35.38% |
| Return on Equity (ROE) | -65.32% | -46.04% | -91.63% | -55.13% | -38.08% |
| Return on Capital Employed (ROCE) | -31.20% | -51.93% | -76.22% | -49.14% | -36.66% |
| Return on Invested Capital (ROIC) | -31.10% | -50.35% | -71.39% | -48.53% | -36.55% |
| Return on Tangible Assets | -30.83% | -39.75% | -65.80% | -44.98% | -37.14% |
| Earnings Yield | -18.27% | -14.96% | -12.15% | -9.53% | -10.52% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.12 | 1.52 | 0.99 | 1.05 | 4.87 |
| Payables Turnover | 3.07 | 2.77 | 3.26 | 1.80 | 1.23 |
| Inventory Turnover | 0.58 | 0.63 | 0.40 | 0.46 | 0.53 |
| Fixed Asset Turnover | 18.61 | 13.01 | 4.72 | 3.89 | 3.61 |
| Asset Turnover | 0.12 | 0.15 | 0.16 | 0.10 | 0.08 |
| Working Capital Turnover Ratio | 0.25 | 0.22 | 0.15 | 0.10 | 0.08 |
| Cash Conversion Cycle | 624.83 | 690.03 | 1163.00 | 935.77 | 469.03 |
| Days of Sales Outstanding | 116.83 | 240.77 | 369.51 | 346.59 | 74.99 |
| Days of Inventory Outstanding | 626.94 | 581.21 | 905.57 | 791.93 | 690.07 |
| Days of Payables Outstanding | 118.95 | 131.95 | 112.08 | 202.74 | 296.02 |
| Operating Cycle | 743.78 | 821.98 | 1275.08 | 1138.52 | 765.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.29 | -0.95 | -1.05 | -1.24 | -1.09 |
| Free Cash Flow Per Share | -1.29 | -0.95 | -1.05 | -1.24 | -1.12 |
| Dividend Paid and CapEx Coverage Ratio | -217.08 | 0.00 | 0.00 | 0.00 | -37.71 |
| Capital Expenditure Coverage Ratio | -217.08 | 0.00 | 0.00 | 0.00 | -37.71 |
| Operating Cash Flow Coverage Ratio | -8.27 | -4.58 | -2.83 | -3.13 | -16.24 |
| Operating Cash Flow to Sales Ratio | -2.37 | -2.20 | -3.10 | -3.86 | -3.25 |
| Free Cash Flow Yield | -16.47% | -12.62% | -9.48% | -8.58% | -7.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.48 | -6.70 | -8.23 | -10.49 | -9.51 |
| Price-to-Sales (P/S) Ratio | 14.48 | 17.41 | 32.66 | 45.03 | 42.46 |
| Price-to-Book (P/B) Ratio | 3.58 | 3.08 | 7.54 | 5.78 | 3.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.07 | -7.93 | -10.55 | -11.66 | -12.71 |
| Price-to-Operating Cash Flow Ratio | -6.10 | -7.93 | -10.55 | -11.66 | -13.05 |
| Price-to-Earnings Growth (PEG) Ratio | -0.20 | 0.39 | 3.79 | 1.31 | -0.48 |
| Enterprise Value Multiple | -4.40 | -4.24 | -8.03 | -7.58 | -7.89 |
| Enterprise Value | 182.20M | 136.11M | 216.78M | 262.53M | 226.04M |
| EV to EBITDA | -4.40 | -4.24 | -8.03 | -7.58 | -7.89 |
| EV to Sales | 11.12 | 12.74 | 30.11 | 39.29 | 32.89 |
| EV to Free Cash Flow | -4.67 | -5.80 | -9.72 | -10.18 | -9.85 |
| EV to Operating Cash Flow | -4.69 | -5.80 | -9.72 | -10.18 | -10.11 |
| Tangible Book Value Per Share | 2.19 | 2.43 | 1.45 | 2.47 | 3.74 |
| Shareholders’ Equity Per Share | 2.19 | 2.44 | 1.47 | 2.50 | 3.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.00 | 0.00 | -0.01 | -0.00 |
| Revenue Per Share | 0.54 | 0.43 | 0.34 | 0.32 | 0.34 |
| Net Income Per Share | -1.43 | -1.12 | -1.35 | -1.38 | -1.50 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.01 | 1.00 |
| Interest Burden | 1.03 | 0.84 | 1.03 | 1.01 | 1.00 |
| Research & Development to Revenue | 1.28 | 1.59 | 2.00 | 2.20 | 2.22 |
| SG&A to Revenue | 1.99 | 2.17 | 1.27 | 1.42 | 1.50 |
| Stock-Based Compensation to Revenue | 0.34 | 0.24 | 0.47 | 0.63 | 1.05 |
| Income Quality | 0.91 | 0.84 | 0.79 | 0.90 | 0.73 |
Currency in CAD